Press releases

GSK’s malaria candidate vaccine receives positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa

GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine RTS,S, in children aged 6 weeks to 17 months.

Read more - GSK’s malaria candidate vaccine receives positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa Read more